Molecular Autism, published by BMC in the United Kingdom, is a premier open-access journal dedicated to publishing high-quality research on the molecular and genetic factors contributing to autism spectrum disorders. Since its inception in 2010, the journal has established itself as a vital resource for researchers and clinicians, offering insights into the developmental biology, neuroscience, and psychiatric dimensions of autism. With an impressive impact factor and rankings placing it in the Q1 category across multiple relevant fields such as Developmental Biology, Developmental Neuroscience, Molecular Biology, and Psychiatry and Mental Health, it serves as a critical platform for the dissemination of innovative research and interdisciplinary collaboration. The journal encourages open dialogue through its commitment to making research freely accessible, thereby advancing knowledge and fostering advances in the understanding of autism. By bridging diverse disciplines and engaging with cutting-edge research, Molecular Autism aims to enhance our understanding of autism's complexities and inform future therapeutic approaches.

Advances in Autism is a prominent academic journal published by Emerald Group Publishing Ltd, dedicated to the comprehensive exploration of autism spectrum disorders through the lenses of Cognitive Neuroscience, Developmental Psychology, and Psychiatry and Mental Health. Since its inception in 2015, the journal has made significant strides in disseminating high-quality research and fostering interdisciplinary collaboration within its diverse scope. With a respectable 2023 impact factor placing it in the Q3 category across multiple relevant fields, including Neurology and Clinical Psychiatry, Advances in Autism serves as an essential resource for researchers, practitioners, and students alike, aiming to advance the understanding of autism and its related challenges. Although currently not open access, the journal provides various subscription options to facilitate widespread access to its cutting-edge insights and empirical studies, making it an indispensable tool for anyone invested in autism research.

Cognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.

Education and Training in Autism and Developmental Disabilities is a prominent journal published by the Council for Exceptional Children, focusing on innovative research and insights in the field of autism and developmental disabilities education. With an evolving scope since its inception, the journal emphasizes the importance of evidence-based practices, pedagogical strategies, and interdisciplinary approaches to enhance educational outcomes for individuals with autism and related conditions. Although it currently holds a Q3 category in Developmental and Educational Psychology and is ranked in the Q2 category in Education, it continues to gain recognition with a respectable placement in Scopus rankings—indicating that it plays a crucial role in informing educational practices and policy decisions. Researchers and practitioners can access a wealth of information through its open access options, underscoring a commitment to disseminating knowledge widely. By bridging the gap between research and real-world application, this journal serves as an essential resource for education professionals seeking to advance their understanding and improve the quality of education for neurodiverse learners.

The INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE is a critical platform for disseminating cutting-edge research in the field of developmental biology and neuroscience. Published by WILEY, this esteemed journal has been contributing to the academic community since its inception in 1983, and continues to serve as a vital resource through to 2024. With an impact factor that reflects its influence in the field—ranking in Q3 for both Developmental Biology and Developmental Neuroscience—this journal presents an opportunity for researchers, professionals, and students alike to engage with pioneering studies and extend their understanding of complex developmental processes. Although not open access, the journal provides an essential repository of knowledge for those seeking to explore the nuances of neurological development and related disciplines. It actively supports academic discourse and research dissemination, thereby playing a significant role in advancing our collective understanding of developmental neuroscience.

JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, published by Lippincott Williams & Wilkins, stands as a pivotal platform for interdisciplinary research in the fields of pediatrics, psychology, and mental health. Established in 1980 and with a comprehensive coverage extending to 2024, this esteemed journal operates within the realms of developmental and educational psychology, medicine, and psychiatry, earning a commendable Q2 ranking in its respective categories as of 2023. Its overarching objective is to disseminate high-quality, peer-reviewed studies that address the intricate interplay between developmental milestones and behavioral health in children. Although it does not currently offer open access, the journal's influential presence in the scholarly community is underscored by its strategic positioning within the Scopus rankings, making it an invaluable resource for researchers, practitioners, and students committed to advancing the health and well-being of children and adolescents.

Behavioral and Brain Functions is a leading Open Access journal published by BMC, dedicated to advancing the field of behavioral neuroscience, cognitive neuroscience, and biological psychiatry since its inception in 2005. This esteemed journal, based in the United Kingdom, has established itself as a vital resource for researchers and professionals, boasting a remarkable influence demonstrated by its Q1 and Q2 rankings across multiple relevant categories. With its commitment to providing unrestricted access to high-quality research, the journal facilitates the dissemination of significant findings in understanding the complex interactions between behavior and brain function. The journal ranks impressively within the Scopus database, positioning itself among the top-tier publications in its categories, making it an essential platform for academic discourse and innovation. As it converges through 2024, Behavioral and Brain Functions continues to play a crucial role in shaping the forefront of neuroscientific inquiry, inviting contributions that challenge our understanding and promote further exploration in these dynamic fields.

CoDAS, an esteemed academic journal published by the SOC BRASILEIRA FONOAUDIOLOGIA, serves as a leading platform for interdisciplinary research within the realms of linguistics, speech, and hearing sciences. Established as an Open Access journal in 2013, it ensures broad dissemination and accessibility of scholarly work, significantly benefitting researchers, clinicians, and students alike. Based in Brazil, CoDAS has garnered credibility with its impressive Q2 ranking in Linguistics and Language, as well as its rankings in Otorhinolaryngology and Speech and Hearing categories, reflecting its substantial contribution to these fields. The journal's impact is underscored by its robust Scopus rankings, including the 67th percentile in Language and Linguistics. With a commitment to fostering innovative research and bridging gaps between theory and practice, CoDAS continues to play a vital role in advancing knowledge and clinical practices in communication disorders and auditory sciences.

The Journal of the Korean Academy of Child and Adolescent Psychiatry (ISSN: 1225-729X; E-ISSN: 2233-9183) stands as a pivotal resource in the fields of child and adolescent mental health, contributing significantly to the dialogue on psychiatric practices and research in South Korea and beyond. Published by the KOREAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY, this journal is recognized for its dedication to advancing the understanding of psychiatric disorders that affect children and adolescents, as evidenced by its Q3 ranking in both Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health categories for 2023. Operated from Seoul, South Korea, the journal facilitates knowledge-sharing among researchers and practitioners, providing insights into clinical practices and innovative treatment methodologies. Although not openly accessible, the journal emphasizes quality over quantity in its selection of studies, making each article a valuable contribution to the field. As the journal continues to publish impactful research through 2024, it remains essential reading for those committed to the well-being of younger populations and their families.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.